{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:18:48Z","timestamp":1773307128761,"version":"3.50.1"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088063","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T21:51:55Z","timestamp":1392069115000},"page":"e88063","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association between Amylin and Amyloid-\u03b2 Peptides in Plasma in the Context of Apolipoprotein E4 Allele"],"prefix":"10.1371","volume":"9","author":[{"given":"Wei Qiao","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Wallack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Liebson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mkaya","family":"Mwamburi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.febslet.2008.05.006","article-title":"Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures","volume":"582(15)","author":"YA Lim","year":"2008","journal-title":"FEBS Lett"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","article-title":"Amyloid beta (Abeta) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways","volume":"287(22)","author":"W Fu","year":"2012","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation","volume":"273(49)","author":"WQ Qiu","year":"1998","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/diabetes.52.9.2315","article-title":"An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures","volume":"52(9)","author":"RG Bennett","year":"2003","journal-title":"Diabetes"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nature05143","article-title":"Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism","volume":"443(7113)","author":"Y Shen","year":"2006","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: A second amyloid in Alzheimer disease?","volume":"(4)","author":"K Jackson","year":"2013","journal-title":"Ann Neurol 74"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19(5)","author":"WA Banks","year":"1998","journal-title":"Peptides"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.peptides.2007.06.011","article-title":"Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat","volume":"28(7)","author":"M Olsson","year":"2007","journal-title":"Peptides"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-3-642-24716-3_10","article-title":"Effects of amylin on eating and adiposity","volume":"(209)","author":"TA Lutz","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MED.0b013e32835b896f","article-title":"Amylin and the regulation of appetite and adiposity: recent advances in receptor signaling, neurobiology and pharmacology GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities","volume":"20(1)","author":"JD Roth","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00005344-199512000-00012","article-title":"Amylin-induced relaxation of the perfused mesenteric arterial bed: meditation by calcitonin gene-related peptide receptors","volume":"26(6)","author":"TC Westfall","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1100\/tsw.2001.23","article-title":"Amylin localization, effects on cerebral arteries and on local cerebral blood flow in the cat","volume":"1","author":"L Edvinsson","year":"2001","journal-title":"Scientific World Journal"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1210\/en.2010-0590","article-title":"Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats","volume":"151(12)","author":"JL Trevaskis","year":"2010","journal-title":"Endocrinology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms","volume":"43(3)","author":"R Deane","year":"2004","journal-title":"Neuron"},{"key":"ref15","volume":"2","unstructured":"Sagare AP, Bell RD, Zlokovic BV (2012) Neurovascular dysfunction and faulty amyloid beta-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med <volume>2<\/volume> (10)."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuint.2009.08.006","article-title":"No correlation between time-linked plasma and CSF Abeta levels","volume":"55(8)","author":"N Le Bastard","year":"2009","journal-title":"Neurochem Int"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer&apos;s disease: progress and problems on the road to therapeutics","volume":"297(5580)","author":"J Hardy","year":"2002","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/WNF.0b013e31823a13d3","article-title":"Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid beta monoclonal antibody solanezumab in Japanese and white patients with mild to moderate alzheimer disease","volume":"35(1)","author":"K Uenaka","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(01)00476-7","article-title":"New frontiers in Alzheimer&apos;s disease genetics","volume":"32(2)","author":"RE Tanzi","year":"2001","journal-title":"Neuron"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer&apos;s disease","volume":"118(1)","author":"RD Bell","year":"2009","journal-title":"Acta Neuropathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpsyc.65.5.542","article-title":"Amyloid-associated depression: a prodromal depression of Alzheimer disease?","volume":"65(5)","author":"X Sun","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/gps.1503","article-title":"The Nutrition, Aging, and Memory in Elders (NAME) study: design and methods for a study of micronutrients and cognitive function in a homebound elderly population","volume":"21(6)","author":"TM Scott","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d","volume":"12(3)","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/gps.1710","article-title":"Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly","volume":"22(6)","author":"WQ Qiu","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/clinchem\/42.11.1817","article-title":"Frequency of phenotype-genotype discrepancies at the apolipoprotein E locus in a large population study","volume":"42(11)","author":"C Lahoz","year":"1996","journal-title":"Clin Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study","volume":"51(4)","author":"R Peila","year":"2002","journal-title":"Diabetes"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","article-title":"Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study","volume":"5(8)","author":"M van Oijen","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","article-title":"Association of low plasma Abeta42\/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease","volume":"64(3)","author":"NR Graff-Radford","year":"2007","journal-title":"Arch Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nm0706-758","article-title":"The ups and downs of Abeta","volume":"12(7)","author":"DJ Selkoe","year":"2006","journal-title":"Nat Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1750-3639.2006.tb00559.x","article-title":"The cerebral beta-amyloid angiopathies: hereditary and sporadic","volume":"16(1)","author":"SX Zhang-Nunes","year":"2006","journal-title":"Brain Pathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.20050","article-title":"Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions","volume":"55(4)","author":"EJ van Dijk","year":"2004","journal-title":"Ann Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/01.wnl.0000191403.95453.6a","article-title":"Plasma beta\u2013amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy","volume":"66(1)","author":"ME Gurol","year":"2006","journal-title":"Neurology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer&apos;s disease","volume":"21(2)","author":"T Kawarabayashi","year":"2001","journal-title":"J Neurosci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1471-4159.2002.00889.x","article-title":"Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer&apos;s disease","volume":"81(2)","author":"RB DeMattos","year":"2002","journal-title":"J Neurochem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(94)92960-2","article-title":"Clinical application of apolipoprotein E genotyping to Alzheimer&apos;s disease","volume":"343(8912)","author":"AD Roses","year":"1994","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410380219","article-title":"Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy","volume":"38(2)","author":"SM Greenberg","year":"1995","journal-title":"Ann Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0167-0115(01)00300-7","article-title":"Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat","volume":"102(2-3)","author":"HA Golpon","year":"2001","journal-title":"Regul Pept"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI8593","article-title":"A genetic dichotomy model for the inheritance of Alzheimer&apos;s disease and common age-related disorders","volume":"104(9)","author":"RE Tanzi","year":"1999","journal-title":"J Clin Invest"},{"key":"ref39","first-page":"E156","article-title":"Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity","volume":"1)","author":"TR Pieber","year":"1994","journal-title":"Am J Physiol 267(1 Pt"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0168-8227(92)90016-K","article-title":"Effects of aging on plasma islet amyloid polypeptide basal level and response to oral glucose load","volume":"15(2)","author":"T Mitsukawa","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"ref41","first-page":"2822","article-title":"Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes","volume":"85(8)","author":"S Makimattila","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e24815","DOI":"10.1371\/journal.pone.0024815","article-title":"Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese","volume":"6(9)","author":"X Hou","year":"2011","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343(6)","author":"JW Hoppener","year":"2000","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1054\/npep.1999.0046","article-title":"Effects of glucagon, insulin, amylin and CGRP on feeding","volume":"33(5)","author":"N Geary","year":"1999","journal-title":"Neuropeptides"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00125-010-1671-6","article-title":"Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?","volume":"53(6)","author":"S Zraika","year":"2010","journal-title":"Diabetologia"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/VHRM.S1978","article-title":"Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk","volume":"4(2)","author":"BJ Hoogwerf","year":"2008","journal-title":"Vasc Health Risk Manag"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T07:45:20Z","timestamp":1597477520000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088063"}},"subtitle":[],"editor":[{"given":"Riqiang","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,10]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088063","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,10]]}}}